Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations
Launched by ELI LILLY AND COMPANY · Oct 18, 2007
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Must be of legal age according to your country.
- • Must have had a history of erectile dysfunction for at least 3 months.
- • Must currently and have been using sildenafil for the last six weeks.
- • Agree to not use any other ED treatment during the study.
- • Anticipate the same female sexual partner for the study.
- Exclusion Criteria:
- • History of other primary sexual disorder
- • Treatment with nitrates
- • Have a penile implant or clinically significant penile deformity
- • History of certain heart problems
- • Do not meet certain lab value reference ranges
About Eli Lilly And Company
Eli Lilly and Company is a global healthcare leader dedicated to creating innovative medicines that improve patient outcomes across a range of therapeutic areas, including diabetes, oncology, immunology, and neurodegenerative diseases. With a rich history of scientific research and a commitment to advancing healthcare, Lilly invests significantly in clinical trials to develop new treatments and enhance existing therapies. The company prioritizes patient safety and ethical standards in its clinical research, fostering collaboration with healthcare professionals and stakeholders to ensure the delivery of high-quality, evidence-based solutions that address unmet medical needs worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, , Brazil
Patients applied
Trial Officials
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials